Recently FDA approved the ECG feature for Garmin smartwatches. Garmin Venu 2 Plus is now the first device to get this feature onboard. However, at present, this update rollout will be available for users in the United States with a promise to come to other regions. The ECG feature is one of the most important aspects of the smartwatch that enables users to track their heart rate with accuracy and get timely updates about their health.
After getting approval from FDA, Garmin will schedule a wider rollout of the ECG feature for more devices and regions. The feature empowers users to get distinguished between normal heart rate and the symptoms of Atrial Fibrillation. Further, users can also record accurate readings of their heart rate through the wrist. To get reading, users have to put their index finger and thumb on the metal edge of the device’s bezel for 30 seconds.
Further, you can send your data and timely heart rate readings to your doctor in PDF format. For that, you have to make settings through Garmin Connect. In the market, Apple is the leader when it comes to ECG accuracy. We can now and then hear the life-saving articles of the Apple Watch series. Samsung is also active in this field with the Galaxy Watch Active2, and Galaxy Watch 5 to have it.
It is interesting to see whether the older editions of smartwatches will get this feature or if it will be available with upcoming smartwatches only. Garmin’s Venu 2 Plus has all the necessary specifications and compatibility for ECG support. However, Garmin aims to expand the support of the ECG feature to its other devices in the coming months.